International Journal of Pharmaceutical Medicine

Report on Drug Safety and the US FDA by the Institute of Medicine
pp. 289-291(3)
Author: Fox, Anthony W.

Human Volunteer Studies − Safety Considerations in an Era of Highly Active Biological Agents: Lessons from the TeGenero Tragedy
pp. 293-296(4)
Author: Snell, Noel J.C.

Paediatric Assessment: An Essential Part of Standard Drug Development
pp. 297-301(5)
Author: Milne, Christopher-Paul

Translational Science in Medicine: Implications for the Pharmaceutical Industry
pp. 303-310(8)
Author: Wehling, Martin

Critical Considerations in Drug Development in Ethnically Diverse Populations
pp. 311-316(6)
Authors: Benatar, Vidal; Lévy, Samuel

Local Clinical Trial Approval Times in the UK
pp. 317-320(4)
Authors: Chester, Paul; Aalam, Sadiah; Cooper, Pauline; Risley, Catherine; Dornhorst, Anne

7th Annual European Congress of Rheumatology: 21−24 June 2006; Amsterdam, The Netherlands
pp. 321-326(6)
Authors: Cameron, Fiona; Crofskey, Sam

Forum: Updates in Pharmaceutical Medicine
pp. 327-330(4)

Summary of Recent Deal Activity: Drug Discovery Technologies
pp. 331-339(9)

Major Pharmaceutical Conferences: November 2006 − May 2007
pp. 341-342(2)

SPM News
pp. 343-343(1)